Cargando…
Corticosteroids for COVID-19 Therapy: Potential Implications on Tuberculosis
On 11 March 2020, the World Health Organization announced the Corona Virus Disease-2019 (COVID-19) as a global pandemic, which originated in China. At the host level, COVID-19, caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), affects the respiratory system, with the clinic...
Autores principales: | Gopalaswamy, Radha, Subbian, Selvakumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038708/ https://www.ncbi.nlm.nih.gov/pubmed/33917321 http://dx.doi.org/10.3390/ijms22073773 |
Ejemplares similares
-
Of tuberculosis and non-tuberculous mycobacterial infections – a comparative analysis of epidemiology, diagnosis and treatment
por: Gopalaswamy, Radha, et al.
Publicado: (2020) -
The Strange Case of BCG and COVID-19: The Verdict Is Still up in the Air
por: Gopalaswamy, Radha, et al.
Publicado: (2020) -
Editorial: Host-Directed Therapies for Tuberculosis
por: Costa, Diego L., et al.
Publicado: (2021) -
Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis
por: Ramasamy, Santhamani, et al.
Publicado: (2021) -
Host-Directed Therapeutic Strategies for Tuberculosis
por: Kolloli, Afsal, et al.
Publicado: (2017)